Vitamin K2 therapy for myelodysplastic syndromes (MDS) and post-MDS acute myeloid leukemia: information through a questionnaire survey of multi-center pilot studies in Japan.
Miyazawa
K
K
Nishimaki
J
J
Ohyashiki
K
K
Enomoto
S
S
Kuriya
S
S
Fukuda
R
R
Hotta
T
T
Teramura
M
M
Mizoguchi
H
H
Uchiyama
T
T
Omine
M
M
D000208:Acute Disease; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D010865:Pilot Projects; D014812:Vitamin K / Q000031:analogs & derivatives* / Q000627:therapeutic use; D024482:Vitamin K 2 / Q000031:analogs & derivatives
D024482:Vitamin K 2; D014812:Vitamin K; C030814:menatetrenone